9th International Conference on Neonatal and Childhood Pulmonary Vascular Disease (Abstracts)

PVRI Member Authors: Jeffrey Fineman

Papers included

  • Assessment of right ventricular function using three-dimensional echocardiography and right ventricular strain in pediatric pulmonary hypertension
  • Effect of unit-wide oxygen saturation target on incidence of pulmonary hypertension in premature infants
  • Pulmonary vasodilator therapy in patients with single-ventricle physiology: effects on saturation, pressure, and progress to Fontan
  • Pulmonary artery hypertension correlates with decreased cardiac output in Fontan patients
  • Obstructive sleep apnea and pulmonary hypertension in pediatrics
  • Acute vasodilator testing in patients with segmental pulmonary vascular disease
  • Pulmonary vasodilator and catheterization therapy for high-risk hypoplastic left heart syndrome
  • Pulmonary vascular dysfunction persists in asymptomatic preterm infants beyond infancy: assessment by pulmonary artery acceleration time
  • Impaired pulmonary vasoconstriction and NO-mediated relaxation pathways in the Sugen-hypoxia model of severe pulmonary hypertension
  • Clinical presentation of a pediatric cohort with pulmonary veno-occlusive disease for lung transplantation
  • Histopathology and computed tomographic findings in a pediatric cohort with pulmonary veno-occlusive disease referred for lung transplantation
  • Increased synchronicity demonstrated by simultaneously recorded heart sounds in subjects with pulmonary hypertension
  • Serial N-terminal pro brain natriuretic peptide levels predicted decreased right ventricular dysfunction in children with pulmonary arterial hypertension
  • Early predictive markers of right ventricular–pulmonary vascular dysfunction in preterm infants with chronic lung disease
  • Pulmonary hypertension during respiratory syncytial virus bronchiolitis is a risk factor for severity of the illness
  • Echocardiographic and biochemical screening for pulmonary hypertension in infants with bronchopulmonary dysplasia
  • Innovative treatment for hemoptysis associated with inoperable pulmonary venous obstruction
  • Single-center use of inhaled treprostinil in pediatric patients at standard and above-standard doses
  • Acoustic diagnosis of pulmonary hypertension: automated speech-recognition-inspired classification algorithm outperformed cardiologists
  • Subcutaneous to oral treprostinil transition: individualize, don't protocolize
  • Late surgical complications and pulmonary regurgitation in tetralogy of Fallot repair predispose to sudden cardiac death
  • Changes in shear metrics correspond to vascular stiffening in pediatric pulmonary hypertension
  • Safety and outcomes of treprostinil in neonates with pulmonary hypertension
  • Short-term use of iloprost to facilitate transition to intravenous epoprostenol in children
  • Pulmonary hypertension in the premature infant population: echocardiographic findings and potential biomarkers
  • Oxygen consumption (VO2) in children with pulmonary hypertension undergoing cardiac catheterization under general anesthesia


Read the full article online


Pregnancy and Pediatrics: Pulmonary Vascular Disease
Pulmonary Arterial Hypertension
Pulmonary Hypertension

Published in:

Pulmonary Circulation Vol 6: No 3 cover image

September 2016

Pulmonary Circulation Vol 6: No 3

View this journal

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI